Skip to main content
Fig. 1 | BMC Veterinary Research

Fig. 1

From: Can cartilage intermediate layer protein 1 (CILP1) use as a novel biomarker for canine myxomatous mitral valve degeneration levels or not?

Fig. 1

Boxplot of serum CILP1 and NT-proBNP levels in healthy controls and dogs with MMVD (a, b). Boxplot of serum CILP1 and NT-proBNP levels in healthy controls (n = 8) and dogs with MMVD staged according to the ACVIM consensus (c, d). Stage B1 (n = 4), stage B2 (n = 6), stage C (n = 15), and stage D (n = 2). The boxplot shows the average value along with the minimum and maximum values. *P < 0.05, **P < 0.01, and ***P < 0.001

Back to article page